In vivo and in vitro Approach to Anti-arthritic and Anti-inflammatory Effect of Crocetin by Alteration of Nuclear Factor-E2-Related Factor 2/hem Oxygenase (HO)-1 and NF-κB Expression
Pharmacology, Toxicology and Pharmaceutical Science
15
19%
Medicine and Dentistry
10
13%
Biochemistry, Genetics and Molecular Biology
5
6%
Immunology and Microbiology
3
4%
Agricultural and Biological Sciences
2
3%
Other
11
14%
Unknown
33
42%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 24 August 2023.
All research outputs
#14,913,965
of 25,383,344 outputs
Outputs from Frontiers in Pharmacology
#4,694
of 19,647 outputs
Outputs of similar age
#225,347
of 450,449 outputs
Outputs of similar age from Frontiers in Pharmacology
#122
of 366 outputs
Altmetric has tracked 25,383,344 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 19,647 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 450,449 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 49th percentile – i.e., 49% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 366 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
